NCT02838368View on ClinicalTrials.gov

Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices

CompletedOBSERVATIONAL
Enrollment

921

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

December 1, 2018

Conditions
Pompe Disease
Trial Locations (1)

92868

University of California, Irvine, Irvine

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

University of California, Irvine

OTHER

NCT02838368 - Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices | Biotech Hunter | Biotech Hunter